Page results
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia.
-
This page aims to help you, your family or carers to plan ahead, and talk about decisions about your care or treatment that may need to be made in the future.
-
The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.
-
Preparations for the festive season are in full swing in the UCLH Charity fundraising team.
-
UCLH is a designated Haemophilia Centre providing a 24/7 service for patients, including those needing treatment with blood products and clotting factor medications.
-
Thalassaemia is a group of inherited blood conditions where the part of the blood known as haemoglobin is abnormal.
-
Complex travel appointments are available through NHS referral or private pay. Please note that an NHS referral is only valid in certain cases.
-
Information about sickle cell disorder and pregnancy for UCLH patients.
-
This patient information offers advice for patients suffering from long COVID regarding a healthy diet and nutrition.
-
This page has been written by the Paediatric and Adolescent Gynaecology team for parents and carers of children with vulvovaginitis.
File results
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis